WHO ICTRP trial
Effect of long-term Insulin on glycemia control in critically ill patients…
IRCT201608182582N14 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201608182582N14 |
|---|---|
| Public title | Effect of long-term Insulin on glycemia control in critically ill patients admitted to intensive care unit |
| Scientific title | Effect of glargine Insulin on glycemia control in critically ill patients admitted to intensive care unit |
| Primary sponsor | Vice Chancellor for Research of Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Diabetes. Insulin-dependent diabetes mellitus;Insulin-dependent diabetes mellitus |
| Interventions | Intervention 1: intervention group: patients will receive 10 IU Glargine daily in addition to regular insulin therapy, subcutaneously. Intervention 2: control group: All patients will receive routine regular insulin therapy which is Regular… |
| Registration date | Nov 7, 2016 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: